Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.105EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.105EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.105ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.105ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.105EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.105EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.105ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.105ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GK.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.13.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.13.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.13.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.13.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.13.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used